Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 11, 2001 - Issue 9
Submit an article Journal homepage
266
Views
28
CrossRef citations to date
0
Altmetric
Miscellaneous

Novel biomaterials for drug delivery

Glenn D Prestwich Professor Glenn D. Prestwich, The University of Utah, Department of Medicinal Chemistry, 30 South 2000 East, Room 201 ,Salt Lake , City, Utah 84112-5820, U.S.A. Tel.: 801 585-9051; Fax.: 801 585-9053, E-mail: [email protected]
&
Yi Luo Professor Glenn D. Prestwich, The University of Utah, Department of Medicinal Chemistry, 30 South 2000 East, Room 201 ,Salt Lake , City, Utah 84112-5820, U.S.A. Tel.: 801 585-9051; Fax.: 801 585-9053, E-mail: [email protected]
Pages 1395-1410 | Published online: 25 Feb 2005

Bibliography

  • LANGER R: Biomaterials and biomedical engineering. Chem. Eng. Sci. (1995) 50(24):4109–4121.
  • LANGER R Biomaterials: new polymers and novel applications. MRS Bull. (1995) 20(8):18–22.
  • LANGER R: Drug delivery and targeting. Nature (1998) 392 (Suppl.):5S–10S.
  • ••Polymeric materials in drug deliverysystems.
  • LANGER R Biomaterial in drug delivery and tissue engineering: one laboratory's experience. Acc. Chem. Res. (2000) 33:94–101.
  • FEIJEN J: The impact of biomaterials on pharmaceutical sciences. Euro. J. Pharm. (1994) 2:7–9.
  • LEMONS JE: Ceramics: past, present, and future. Bone (1996) 19(1 Suppl.):121S–128S.
  • •Recent paper describing the development of ceramics as implants and its application in drug delivery.
  • KIMAKHE S, BOHIC S, LARROSE C et al.: Biological activities of sustained Polymyxin B release from calcium phosphate biomaterial prepared by dynamic compaction: an in vitro study. J. Biomed. Mater. Res. (1999) 47(1):18–27.
  • GAUTIER H, CAILLON J, LE RAY AM, DACULSI G, MERLE C: Influence of isostatic compression on the stability of vancomycin loaded with a calcium phosphate-implantable drug delivery device. J. Biomed. Mater. Res. (2000) 52(2):308–314.
  • GUICHEUX J, GAUTHIER O, AGUADO E et al.: Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study. J. Bone Miner. Res. (1998) 13(4):739–748.
  • GUICHEUX J, KIMAKHE S, HEYMANN D, DACULSI G: Growth hormone stimulates the degradation of calcium phosphate biomaterial by human monocytes/ macrophages in vitro. J. Biomed. Mater. Res. (1998) 40(1):79–85.
  • GAUTIER H, GUICHEUX J, GRIMANDI G, FAIVRE-CHAUVET A, DACULSI G, MERLE C: In vitro influence of apatite-granule-specific area on human growth hormone loading and release. J. Biomed. Mater. Res. (1998) 40(4):606–613.
  • LAMBOTTE JC, THOMAZEAU H, CATHELINEAU G, LANCIEN G, MINET J, LANGLAIS F: Tricalcium phosphate, an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits. Chirurgie (1998) 123(6):572–9.
  • TAGAI T, HOSHI T, YAMADA T: Development of the porous apatitic materials. Kobutsugaku Zasshi (1997) 26(2):59–62.
  • RODRIGUEZ-LORENZO LM, SALINAS AJ, VALLET-REGI M, SAN ROMAN J: Composite biomaterials based on ceramic polymers. I. Reinforced systems based on A1203/PMMA/PLLA. J. Biomed. Mater. Res. (1996) 30(4):515–522.
  • HOFFMAN AS: Synthetic polymeric biomaterials. In: Polymeric materials and artificial organs. Gebelein Cg (Ed.). American Chemical Society, Washington DC, USA (1984):13–19.
  • HANES J, CHIBA M, LANGER R Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. Biomaterials (1998) 19 (1-3) :163–172.
  • KIM D-D, TAKENO MM, RATNER, HORBETT TA: Glow discharge plasma deposition (GDPD) technique for the local controlled delivery of hirudin from biomaterials. Pharm. Res. (1998) 15(5):783–786.
  • SERIZAWA T, UCHIDA T, AKASHI M: Synthesis of polystyrene nanospheres having lactose-conjugated hydrophilic polymers on their surfaces and carbohydrate recognition by proteins. J. Biomater. Sci., Polym. Ed (1999) 10(3):391–401.
  • ••Site-specific drug carrier of lactoseconjugated polystyrene nanosphere.
  • BRUINING MJ, EDELBROEK-HOOGENDOORN PS, BLAAUWGEERS HGT, MOOY CM, HENDRIKSE FH, KOOLE LH: New biodegradable networks of poly(N-vinylpyrrolidinone) designed for controlled nonburst degradation in the vitreous body. J. Biomed. Mater. Res. (1999) 47(2):189–197.
  • SCHWARTE LM, PODUAL K, PEPPAS NA: Cationic hydrogels for controlled release of proteins and other macromolecules. ACS Symp. Ser. (1998) 709:56–66.
  • •Tailored polymeric materials for controlled delivery systems.
  • PEPPAS NA, KEYS KB, TORRES LM, LOWMAN AM: Poly (ethylene glycol)-containing hydrogels in drug delivery. J. Controlled Release (1999) 62(1-2):81–87.
  • •Mucoadhesive PEG star polymer hydrogels for protein delivery
  • BELL CL, PEPPAS NA: Swelling/syneresis phenomena in gel-forming interpolymer complexes. J. Biomater. Sci. Polym. Ed. (1996) 7(8):671–683.
  • JO S, PARK K: Novel poly(ethylene glycol) hydrogels from silylated PEGs. J. Bioact. Compat. Polym. (1999) 14(6):457–473.
  • HASSAN CM, STEWART JE, PEPPAS NA: Diffusional characteristics of freeze/thawed poly(vinyl alcohol) hydrogels: Application to protein controlled release from multilaminate devices. Euro. J. Pharm. Biopharm. (2000) 49(2):161–165.
  • NUTTELMAN CR, ANSETH KS: Attachment of proteins to poly(vinyl alcohol) for biomedical applications. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) (2000) 41(2):1685–1686.
  • GRIFFITH LG: Polymeric biomaterials. Acta Mater. (2000) 48:263–277.
  • ••Recent review on the polymeric biomaterialdevelopment and applications.
  • LI S: Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J. Biomed. Mater. Res. (1999) 48:342–353.
  • •Recent review on the degradation mechanism of PLGA polymers.
  • SUH H, JEONG B, RATHI R, KIM SW: Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethyleneoxide)-poly-(lactide/glycolide) nanospheres. J. Biomed. Mater. Res. (1998) 42(2):331–338.
  • KREITZ MR, DOMM JA, MATHIOWITZ E: Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide). Biomaterials (1997) 18(24):1645–1651.
  • BEMOIT MA, MOUSSET B, DELLOYE C, BOUILLET R, GILLARD J: Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int. Orthop. (1997) 21(6):403–408.
  • SANCHEZ A, GUPTA RK, ALONSO MJ, SIBER GR, LANGER R Pulsed controlled-release system for potential use in vaccine delivery. J. Pharm. Sci. (1996) 85(0:547–552.
  • NOBES GAR, MARCHESSAULT RH, MAYSINGER D: Polyhydroxyalkanoates: Materials for delivery systems. Drug Delivery (1998) 5:161–177.
  • ••Recent review on polyhydroxyalkanoates indrug delivery.
  • MATHIOWITZ E, JACOB JS, JONG YS et al.: Biologically erodable microspheres as potential oral drug delivery systems. Nature (1997) 386:410–414.
  • ••Bioerodable polyanhydride microspheres inoral drug delivery.
  • MULLER H-M, SEEBACH D: Poly(hydroxyalkanoates): a fifth class of physiologically important organic biopolymer? Angela Chim. Intl. Ed. Engl. (1993) 32:477–502.
  • CHAPUT C, YAHIA LH, SELMANI A, RIVARD C-H: Natural poly(hydroxy-butyrate-hydroxyvalerate) polymers as degradable biomaterials. Mater. Res. Soc. Symp. Proc. (1995) 385(Polymer/Inorganic Interfaces 2):49–54.
  • GURSEL I, BALCIK C, ARICA Y, AKKUS O, AKKAS N, HASIRCI V: Synthesis and characterization of PHBV and PHEMA interpenetrating networks. Proc. Int. Symp. Controlled Release Bioact. Mater. (1997) 24th:1045–1046.
  • •Hydrophilicity and hydrophobicity balanced PHBV and PHEMA interpenetrating networks.
  • ELIGIO T, RIEUMONT J, SANCHEZ R, SILVA JFS: Characterization of chemically modified poly(3-hydroxyalkanoates) and their performance as matrix for hormone release. Angew. Makromol Chem. (1999) 270:69–75.
  • KOBAYASHI H, SHIRAKI K, IKADA Y: Toxicity test of biodegradable polymers by implantation in rabbit cornea. J. Biomed Mater. Res. (1992) 26:1463–1476.
  • WADE CWR, HEGYELI AF, KULKARNI RK: Standards for in-vitro and in-vivo comparison and qualification of bioabsorbable polymers. J. Test. Eyed. (1977) 5:397–400.
  • JALIL R-U: Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) polymers in sustained drug delivery. Drug Dev. Ind. Pharm. (1990) 16:2353–2367.
  • ENGELBERG I, KOHN J: Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials (1991) 12:290–304.
  • RAMCHANDANI M, PANKASKIE M, ROBINSON D: The influence of manufacturing procedure on the degradation of poly(lactide-co-glycolide) 85:15 and 50:50 implants. J. Controlled Release (1997) 43(2,3):161–173.
  • RAMCHANDANIA M, ROBINSON D: In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J. Controlled Release (1998) 54(2):167–175.
  • MORITA T, SAKAMURAY, HORIKIRI Y, SUZUKI T, YOSHINO H: Protein encapsulation into biodegradable microspheres by a novel 5/0/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J. Controlled Release (2000) 69(3):435–444.
  • GASPAR MM, BLANCO D, CRUZ MEM, ALONSO MJ: Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influences of polymer properties on enzyme loading, activity and in vitro release. J. Controlled Release (1998) 52:53–62.
  • ROSA GD, IOMMELI R, LA ROTONDA MI, MIRO A, QUAGLIA F: Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J. Controlled Release (2000) 69(2):283–295.
  • EGILMEZ NK, JONG YS, SABEL MS, JACOB JS, MATHIOWITZ E, BANKERT RB: In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res. (2000) 60(14):3832–3837.
  • CLELAND JL, JONES AJS: Stable formulation of recombinant human growth factor hormone and interferon-y for microencapsulation in biodegradable microspheres. Pharm. Res. (1996) 13(10):1464–1475.
  • CLELAND JL, MAC A, BOYD B et al.: The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. (1997) 14(4):420–425.
  • LU L, STAMATAS GN, MIKOS AG: Controlled release of transforming growth factor 131 from biodegradable polymer microparticles. J. Biomed. Mater. Res. (2000) 50:440–451.
  • ZHU G, MALLERY SR, SCHWENDEMAN SP: Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nature Biotech. (2000) 18:52–57.
  • PEAN J-M, BOURY F, VENTER-JULIENNE M-C, MENEI P, PROUST J-E, BENOIT J-P: Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres? Pharm. Res. (1999) 16(8):1294–1299.
  • PETTIT DK, LAWTER JR, HUANG WJ et al.: Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSE Pharm. Res. (1997) 14(10):1422–1430.
  • JEONG B, CHOI K, BAE YH, ZENTNER G, KIM SW: New biodegradable polymers for injectable drug delivery systems. J. Controlled Release (1999) 62:109–114.
  • JEONG B, BAE YH, KIM SW: Biodegradable block copolymers as injectable drug-delivery systems. Nature (1997) 388:860–862.
  • ••Temperature sensitive PEO-PLA copolymeras injectable drug carrier.
  • LUCKE A, TESSMAR J, SCHNELL E, SCHMEER G, GOPFERICH k Biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials. Biomaterials (2000) 21(23):2371–2370.
  • SAITO N, OKADA T, TOBA S, MIYAMOTO S, TAKAOKA K: New synthetic absorbable polymers as BMP carriers: Plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers. J. Biomed. Mater. Res. (1999) 47(1):104–110.
  • MOLINA I, LI S, MARTINEZ MB, VERT M: Protein release from physically crosslinked hydrogels of the PLA/PEO/PLA triblock copolymer-type. Biomaterials (2001) 22:363–369.
  • ••Physically crosslinkecl PLA/PEO/PLAhydrogel in protein delivery.
  • GOODWIN CJ, BRADEN M, DOWNES S, MARSHALL NJ: Release of bioactive human growth hormone from a biodegradable material: poly(E-caprolactone). J. Biomed. Mater. Res. (1998) 40(2):204–213.
  • LI SM, CHEN XH, GROSS RA, MCCARTHY SP: Hydrolytic degradation of PCL/PEO copolymers in alkaline media. J. Mater. Sci. Mater. Med. (2000) 11(4):227–233.
  • FENG Y, KLEE D, HOCKER H: New biomaterial. Triblock copolymers of poly D(S)-isobutyl-morpholine-2,5-dionei-poly(ethylene oxide). Materiahviss. Werkstoffiech. (1999) 30(12):862–868.
  • JOHN G, MORITA M: Synthesis and characterization of photo-crosslinked networks based on L-lactide/serine copolymers. Macromolecules (1999) 32(6):1853–1858.
  • ••Photocrosslinking of acrylatecl poly(L-lactide/serine) to form polymer networks and beads in drug delivery, copolymerisation with HEMA to be a degradable hydrogel.
  • WON CY, CHU CC, YU TJ: Novel amine-containing biodegradable polyester via copolymerisation of aspartic anhydride and 1,4-cyclohexanedimethanol. Macromol. Rapid Commun. (1996) 17(9):653–659.
  • KIM Y, ZENG F, ZIMMERMAN SC: Peptide dendrimers from natural amino acids. Chem. Euro. J. (1999) 5(7):2133–2138.
  • •Biodegradable dendrimers from natural amino acids.
  • EL-SAYED M, NAIMARK M, KIANI MF, GHANDEHARI H: Transport of macromolecular drug carriers across microvascular beds. Polym. Prep. (Am. Chem. Soc. Div. Polym. Chem.) (2000) 41 (2) :1726–1727.
  • CAMPELL P, GLOVER GL, GUNN JM: Inhibition of intracellular protein degradation by pepstatin, poly(L-lysine) and pepstatinyl-poly(L-lysine). Arch. Biochem. Biophys. (1980) 203:676–680.
  • JEONG SY, KIM SW: Biodegradable polymeric drug delivery systems. Arch. Pharm. Res. (1986) 9(2):63–73.
  • LI C, YU D, NEWMAN RA et al.: Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res. (1998) 58:2404–2409.
  • KISHIDA A, GOTO H, MURAKAMI K, KAKINOM K, AKASHI M: Polymer drugs and polymeric drugs. IX: synthesis and 5-fluorouracil release profiles of biodegradable polymeric prodrugs y-poly(a-hydroxy-methyl-5-fluoro-uracil-glutamate). J. Bioact. Compat. Polym. (1998) 13:222–233.
  • KISHIDA A, MURAKAMI K, GOTO H, AKASHI M: Polymer drugs and polymeric drugs. X: slow release of 5-fluorouracil from biodegradable poly(y-glutamic acid) and its benzyl ester matrices. J. Bioact. Compat. Polym. (1998) 13:270–278.
  • YOSHIDA M, ASANO M, OMICHI H,80. KATAKAI R: Environmental responsive polymers based on pendant a-amino acid groups. Hoshasen (1993) 19(3):27–37.
  • •Temperature sensitive loosely crosslinked poly(acryloyl-L-proline methyl ester).
  • NAGARSEKAR A, CRISSMAN J, CRISSMAN M, FERRARI F, CAPPELLO J, 81. GHANDEHARI H: Synthesis and characterization of pH and temperature sensitive silk-elastin-like block copolymers for controlled drug delivery. Abstr. Pap. Am. Chem. Soc. (2000) 220th: OLY-317.82.
  • ••The development of a protein-based blockcopolymer biomaterials for stimuli-sensitive drug delivery systems using genetic•engineering techniques.
  • MEYER DE, KONG GA, DEWHIRST MW, ZALUTSKY MR, CHILKOTI A: Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res. (2001) 61:1548–1554.
  • ••Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
  • YU Y-C, TIRRELL M, FIELDS GB: Minimal lipidation stabilizes protein-like molecular architecture./ Am. Chem. Soc. (1998) 120(39):9979–9987.
  • SCHWARZE SR, HO A, VOCERO-AKBANI A, DOWDY SF: In vivo protein transduction: Delivery of biologically active protein into the mouse. Science (1999) 285:1569–1572.
  • ••Protein transduction by TAT peptidesequence.
  • YU C, KOHN J: Tyrosine-PEG-derived poly(ether carbonate)s as new biomaterials part. I: synthesis and evaluation. Biomaterials (1999) 20(3):253–264.
  • KOHN J, LANGER R Poly(iminocarbonates) as potential biomaterials. Biomaterials (1986) 7(3):176–182.
  • KOHN J: Optimization of biocompatibility and materials properties in the design of degradable biomaterials. Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.) (1991) 32(2):223–224.
  • •Design of biodegradable polymers with defined physical, chemical, biological properties.
  • DAHIYAT BI, RICHARDS M, LEONG KW: Controlled release from poly(phosphoester) matrices. J. Controlled Release (1995) 33(1):13–21.
  • HELLER J, BARR J, NG S et al.: Development of a new family of poly(ortho esters) and their application in protein and bupivacaine delivery. Tenth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, Utah, USA, (2001) 49–52.
  • HELLER J, NG SY, PENHALE DW, FRITZINGER BK: Use of poly(ortho esters) for the controlled release of 5-fluorouracil and a LHRH analogue. J. Controlled Release (1987) 6:217–224.
  • HELLER J: Development of poly(ortho esters): A histological review. Biomaterials (1990) 11:659–665.
  • A review on the development and biomedical application of poly(ortho ester).
  • MERKLI A, TABATABAY C, GURNY R: Use of insoluble biodegradable polymers in ophthalmic systems for the sustained release of drugs. Euro. J. Biopharm. (1995) 41(5):271–283.
  • ALLCOCK HR, HYMER WC, AUSTIN PE: Diazocoupling of catecholamines with poly(organophosphazenes). Macromolecules (1983) 16:1401–1408.
  • WANG G, HOLLINGS WORTH RI: Synthesis and properties of a bipolar, bisphosphatidyl ethanolamine that forms stable 2-dimensional self-assembled bilayer systems and liposomes. J. Org. Chem. (1999) 64(11):4140–4147.
  • REMUNAN-LOPEZ C, LORENZO-LAMOSA ML, VILA-JATO JL, ALONSO MJ: Development of new chitosan-cellulose multicore microparticles for controlled drug delivery. Euro. J. Pharm. Biopharm. (1998) 45(1):49–56.
  • BOUHADIR KB, YUE I, CHEN L, HAUSMAN D, MOONEY DJ: Synthesis and crosslinking of partially oxidized alginate for tissue engineering applications. Book of Abstracts, 216th ACS National Meeting, Boston, USA August 23–27 (1998): BTEC–078.
  • BOUHADIR KH, ROWLEY JA, KRUGER GM, LEE KY, MOONEY DJ: Biodegradable hydrogels for controlled cell and drug delivery. Book of Abstracts, 217th ACS National Meeting, Anaheim, California, USA March 21–25 (1999): OLY–175.
  • LEE KY, PETERS MC, ANDERSON KW, MOONEY DJ: Controlled growth factor release from synthetic extracellular matrices. Nature (2000) 408:998–1000.
  • ••Mechanical-stimuli controlled growth factorrelease from alginate hydrogel. hyaluronate-hydroxyethyl acrylate blend hydrogel for controlled release device. Chem. Pharm. Bull. (2000) 48(6):850–854. Hybrid hydrogels assembled from synthetic Temperature sensitive hybrid hydrogels
  • PRESTWICH GD, LUO Y, ZIEBELL MR, VERCRUYSSE KP, KIRKER KR, MACMASTER JS: Chemically-modified hyaluronan: new biomaterials and probes for cell biology. Int. Congr. Ser. (2000) 1196:181-194 New Frontiers in Medical Sciences: Redefining Hyaluronan.
  • •Hyaluronan derivatives in drug delivery, wound healing and cell biology study.
  • VERCRUYSSE KP, PRESTWICH GD: Hyaluronate derivatives in drug delivery Crit. Rev. Therap. Drug Carr. Syst. (1998) 15:513–555.
  • ••Hyaluronan derived biomaterials in drugdelivery application.
  • LUO Y, KIRKER KR, PRESTWICH GD: Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery. J. Controlled Release (2000) 69:169–184.
  • LUO Y, PRESTWICH GD: Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem. (1999) 10:755–763.
  • LUO Y, ZIEBELL MR, PRESTWICH GD: A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules (2000) 1:208–218.
  • RADICE M, BURN P, CORTIVO R, SCAPINELLI R, BATTALIARD C, ABARTANGELO G: Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors./ Biomed. Mater. Res. (2000) 50:101–109.
  • •Benzyl ester derived hyaluronan scaffold in tissue engineering.
  • CAMPOCCIA D, DOHERTY P, RADICE M, BRUN P, ABATANGELO G, WILLIAM DF: Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials (1998) 19:2101–2127.
  • FRIESS W: Collagen. Biomaterial for drug delivery. Euro. J. Pharm. Biopharm. (1998) 45(2):113–136.
  • ••Recent review on collagen in drug delivery.
  • RAO KP: Recent developments of collagen-based materials for medical applications and drug delivery systems. J. Biomater. Sci. Polym. Ed. (1995) 7(7):623–45.
  • KUIJPERS AJ, ENGBERS GHM, KRIJGSVELD J, ZAAT SAJ, DANKERT J, FEIJEN J: Crosslinking and characterization of gelatin matrices for biomedical applications. J. Biomater. Sci., Polym. Ed. (2000) 11(3):225–243.
  • INUKAI M, JIN Y, YOMOTA C, YONESE M: Preparation and characterization of hyaluronate-hydroxyethyl acrylate blend hydrogel for controlled release device. Chem. Pharm. Bull. (2000) 48(6):850–854.
  • WANG C, STEWART RJ, KOPECEK J: Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature (1999) 397(6718):417–20
  • •• Temperature sensitive hybrid hydrogels from synthetic polymers and coiled-coil protein domains.
  • KURISAWA M, TERANO M, YUI N: Double-stimuli-responsive degradation of hydrogels consisting of oligopeptide-terminated poly(ethylene glycol) and dextran with an interpenetrating polymer network. J. Biomater. Sci., Polym. Ed. (1997) 8(9):691–708.
  • ••The biodegradability of IPN structuredhydrogel based on oligopeptide-terminated PEG and dextran exhibiting a double-stimuli-response function.
  • SASTRY TP, MADHAVAN V, NAZER MN, GOMATHINAYAGAM S, ROSE C, RAO NM: Graft copolymerization of glycidyl methactylate onto fibrin prepared from slaughter-house waste. J. Macromol Sci., Pure Appl. Chem. (1997) A34(5):915–925.
  • OOYA T, YUI N: Supramolecular-structured polymers for drug delivery. ACS Symp. Ser. (2000) 752:375-384 Controlled Drug Delivery.
  • •A stimuli-responsive polyrotaxane with supermolecular architecture assembled by cydodextrins threaded onto a PEG chain. Patents

Websites

  • PRESTWICH GD: Biomaterials from chemically-modified hyaluronan. Glycoforum (2001): http://glycoforum.gr.jp/science/ hyaluronan/HA18/HA18E.html
  • ••Recent review on the chemical modificationof hyaluronan.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.